REVA Medical : Extension of Voluntary Suspension of Trading

5 March 2019

ASX Limited Advisor Listings 20 Bridge Street Sydney NSW 2000

Dear Ms. Banh,

Voluntary Suspension

Reva Medical, Inc. (ASX: RVA, the "Company") requests that its shares continue to be voluntarily suspended from trading.

The Company voluntarily suspended trading on 24 February 2019 while in discussions with representatives of certain major debt and equity holders to address (i) the Company's immediate financial needs and (ii) the Company's outstanding indebtedness and capital structure moving forward. At this stage discussions and meetings are ongoing. Therefore, the Company is not able, at this time, to provide an update on its financing.

In accordance with ASX Listing Rule 17.2:

• 1. the Company extends the voluntary suspension until it can finalize its plans and provide the market with an accurate update on its future plans;

• 2. the Company expects the voluntary suspension to continue until plans are finalized and an announcement is made to the ASX in this regard. At this stage it expects to be able to do so by 13 March 2019;

3.

The event to which will end the voluntary suspension will be the announcement referred to in paragraphs 1 and 2.

Best regards,

_____________________________ Leigh Elkolli, Company Secretary

HEAD OFFICE: 5751 Copley Drive, San Diego, CA 92111 • [phone] • [phone] (FAX) •www.revamedical.com

AUSTRALIAN OFFICE: Suite 4, Level 14, 6 O'Connell Street, Sydney NSW 2000 • [phone]

ARBN 146 505 777 • REVA Medical, Inc., is a foreign company incorporated in Delaware, USA, whose stockholders have limited liability